Arshad, H.M.E. (2025) “Survival impact and safety comparison of pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A meta-analysis”, Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 42(3), p. 16432. doi:10.36141/svdld.v42i3.16432.